Compound 48/80-lnduced conjunctivitis in the mouse: Kinetics, susceptibility, and mechanism

International Archives of Allergy and Immunology

Volumn 109, Issue 3, 1996, Pages 277-285

  Li, Qian ^a   Luyo, Deborah ^a   Hikita, Naofumi ^a   Whitcup, Scott M ^b   Chan, Chi Chao ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

Allergic mouse; Compound 48 80; Compound 48 80 induced; Conjunctivitis; Goblet cell; Late phase inflammatory reactions; Mast cell degranulation

Indexed keywords

COMPOUND 48-80;

ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; EOSINOPHIL; ERYTHEMA; FEMALE; GOBLET CELL; HISTOPATHOLOGY; INFLAMMATION; KINETICS; MACROPHAGE; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CELL CYCLE; CELL MOVEMENT; CONJUNCTIVITIS, ALLERGIC; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; MAST CELLS; MICE; MICE, INBRED A; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; P-METHOXY-N-METHYLPHENETHYLAMINE;

EID: 0030059514     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237250     Document Type: Article

References (30)

1. Friedlaender MH: Current concepts in ocular allergy. Ann Allergy 1991;67:5-14.
2. Allansmith MR. Baird RS. Bloch KJ: Degranulation of ocular mast cells in rats undergoing systemic anaphylaxis. Invest Ophthalmol Vis Sci 1980;19:1521-1524.
3. Trocmé SD, Bonini S, Trocme MC, Barney NP, Bloch KJ, Allansmith MR: A hapten model of topically induced ocular anaphylaxis in rats. Invest Ophthalmol Vis Sci 1987:28:264-269.
4. Bonini S, Bonini S. Bucci MB, Berruto A. Allansmith MR: Allergen dose response and late symptoms in a human model of ocular allergy. J Allergy Clin Immunol 1990:86:869-876.
5. Allansmith MR, Baird RS, Bloch KJ: Anaphylaxis of ocular adnexa induced by injection of anti-IgE antibody. Exp Eye Res 1985:40:797-804.
6. Udell IJ. Abelson MB: Animal and human ocular surface response to a topical nonimmunc mast-cell degranulating agent (compound 48/ 80). Am J Ophthalmol 1981:91:226-230.
7. Allansmith MR, Baird RS, Ross RN, Barney NP, Bloch KJ: Ocular anaphylaxis induced in the rat by topical application of compound 48/ 80. Dose response and lime course study. Acta Ophthalmol (Copenh.) 1989;67:145-153.
8. Tuffin DP, Fein berg JG: Leukocyte infiltration into the conjunctiva following topical challenge with antigen, histamine, or compound 48/80: in Rother KO, de Week Al. (eds): Mediators of the Immediate Type Inflammatory Reaction. Monogr Allergy Basel, Karger. 1977. vol 12. pp 213-215.
9. Stcnback II. Krootila K. Palkama A. Usitalo II: Mast cells in the anterior uvea of the rabbit: Intraocular effects of compound 48 80 in the rabbit. Exp Eye Res 1992;54:247-252.
10. Ebi Y. Kasugai T. Seino Y. Onoue H, Kanemoto T, Kitamura Y: Mechanism of mast cell deficiency in mutant mice of mi/mi genotype: An analysis by co-culture of mast cells fibroblasts. Blood 1990:75:1247-1251.
11. T1. in vernal conjunctivitis and giant papillary conjunctivitis.J Allergy Clin Immunol 1990;86:34-40.
12. Barney NP. Briggs RM. Bloch K.I. Allansmith MR: Mast cell subpopulations in the conjunctiva. Invest Ophthalmol Vis Sci 1988:29:66.
13. Paton WDM: The mechanism of histamine release. Ciba Found Symp 1956:59-78.
14. Joneja JMV. Biclory L: Understanding Allergy. Sensitivity, and Immunity. New Brunswick, Rutgers University Press, 1990. pp 124-145.
15. Abelson MB. Schaeffer K; Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993:38:115-132.
16. Paton WDM: Compound 48 80: A potent histamine liberator. Br J Pharmacol 1951:6:499-508.
17. Johnson AR. Moran NC: Release of histamine from rat mast cells: A comparison of the effect of compound 48/80 and two antigcn-antibody systems. FedProc 1969:28:1716-1720.
18. Hsu SM. Raine L. Fanger H: The use of avidin-biotin-pcroxidasc complex (ABC) in immuno-peroxidasc technique: A comparison between ABC and unlabeled antibody (PAP) procedure. J Histochcm Cytochem 1981:92:577-580.
19. Lemanske RF Jr. Kaliner MA: Late-phaseallergic reactions: in Middleton E Jr, Reed CE. Elliott FK. Adkinson NF Jr. Yungingcr JW, Busse WW (eds): Allergy: Principles and Practice. St. Louis. Mosby, 1993. pp 320-361.
20. Trocme SD, Bonini S, Barney NP, Bloch KJ, Allansmith MR: Late-phase reaction in topically induced ocular anaphylaxis. Curr Eye Res 1988:7:437-443.
21. Wershil BK. Wang ZS, Gordon JR, Galli SJ: Recruitment of neutrophils during IgE-depend-cnt cutaneous late phase reactions in the mouse is mast cell dependent. J Clin Invest 1991;87: 446-453.
22. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990:346:274-276.
23. Galli SJ, Wershil BK, Gordan JR, Martin TR: Mast cells: Immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses. Ciba Found Symp 1989:147:53-73.
24. Edelman GM: Cellular Selection and Regulation in the Immune response. New York: Raven Press. 1974. pp 101-120.
25. Leiferman KM. Fujisawa T. Gray BH, Gleich GJ: Extracellular deposition of eosinophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990:62:579-589.
26. Lemp MA. W'olflcy DE: The lacrimal apparatus; in William MH Jr (cd): Adler's Physiology ofthc Eye. St. Louis. Mosby. 1993. pp 18-28.
27. Lake AM. Bloch KJ. Neutra MR. Walker WA: Intestinal goblet cell release II In vivo stimulation by antigen in the immunized rat. J Immunol 1979;122:834-837.
28. Lake AM. Bloch KJ. Sinclair KJ. Walker WA: Anaphylactic release of intestinal goblet cell mucus. Immunology 1980:39:173-178.
29. Walker WA, Wu M, Bloch KJ: Stimulation by immune complexes of mucus release from goblet cells of the rat small intestine. Science 1977; 197:370.
30. Allansmith MR. Baird RS. Bloch KJ: Effect of anaphylaxis on conjunctival goblet cells. J Allergy Clin Immunol 1985;76:200-206.